Your browser doesn't support javascript.
loading
Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia.
Tierens, Anne; Kagotho, Elizabeth; Shinriki, Satoru; Seto, Andrew; Smith, Adam C; Care, Melanie; Maze, Dawn; Sibai, Hassan; Yee, Karen W; Schuh, Andre C; Kim, Dennis Dong Hwan; Gupta, Vikas; Minden, Mark D; Matsui, Hirotaka; Capo-Chichi, José-Mario.
Afiliação
  • Tierens A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Kagotho E; Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Nairobi, Kenya.
  • Shinriki S; Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Seto A; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
  • Smith AC; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Care M; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
  • Maze D; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
  • Sibai H; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Yee KW; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Schuh AC; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kim DDH; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Gupta V; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Minden MD; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Matsui H; Department of Medicine Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Capo-Chichi JM; Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Front Oncol ; 13: 1153082, 2023.
Article em En | MEDLINE | ID: mdl-37434984
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá